-
The New Avenue for Access? European Market Access Routes Outside Traditional Public Payer Pathways
Sep 9, 2025, 16:22 PM -
Measurement of Functional Outcome Using the Modified Rankin Scale in Patients With Acute Ischemic Stroke
Sep 9, 2025, 16:22 PM -
The Statistical Abyss: Real-World Evidence for Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Evolution of MRD in Hemato-Oncology Clinical Development
Sep 9, 2025, 16:22 PM -
High Entry Costs Slower Growth: A Nationwide Register Study on Newly Reimbursed Biologic Medicines in Finland 2011-2021
Sep 9, 2025, 16:22 PM -
Five-Year Clinical and Economic Impact of 20 Weight Loss in Adults With Obesity in Saudi Arabia: A Public Healthcare Perspective
Sep 9, 2025, 16:22 PM -
The Role of Unpaid Work in Measuring the Social Costs of Disease
Sep 9, 2025, 16:22 PM -
How Societal Is Sweden? A Study of Inclusion of Societal Costs in Swedish Reimbursement Decisions
Sep 9, 2025, 16:22 PM -
Reducing Premature Cancer Mortality Through Early Stage Treatment: A Markov Model Analysis of Pembrolizumab Across Four Tumor Types
Sep 9, 2025, 16:22 PM -
Long-Term Economic Impact of Nonpersistence to Disease-Modifying Therapies in a Cohort of German Patients With Multiple Sclerosis
Sep 9, 2025, 16:22 PM -
Impact of Real-World Effectiveness vs. Previous Assumptions on Estimates of Economic and Clinical Benefit of 20-Valent Pneumococcal Conjugate Vaccine in Adults Across Countries
Sep 9, 2025, 16:22 PM -
Reconsidering Generic Utilities: Implications for Equitable Health Technology Appraisal
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life (HRQoL) and Its Associated Factors among Chinese Gout Patients: Baseline Findings From a Survey Study
Sep 9, 2025, 16:22 PM -
Bridging National and EU HTA Regulation: Policy Responses to the JCA Rollout
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in the UK
Sep 9, 2025, 16:22 PM -
Economic and Social Burden of Pulmonary Hypertension in Italy
Sep 9, 2025, 16:22 PM -
Changes in Medical Technology Availability in Europe Between 2000 and 2020
Sep 9, 2025, 16:22 PM -
Through a Glass Darkly: The What, How, and What Now for Global Net Price Transparency
Sep 9, 2025, 16:22 PM -
The Longevity Conundrum: Population Aging in the UK
Sep 9, 2025, 16:22 PM -
Increased Adherence to Biologic Therapies Leads to Lower All-Cause and Asthma-Related (HCRU) Costs in Severe Asthma
Sep 9, 2025, 16:22 PM
